TMED Holdings Information

TMED is an equity ETF with a total of 117 individual holdings. The top holdings are Eli Lilly and Company stock at 5.73%, Alnylam Pharmaceuticals at 5.26%, UnitedHealth Group at 5.24%, Thermo Fisher Scientific at 3.64%, and Insulet at 3.62%.

Total Holdings

117

Top 10 Percentage

39.00%

Asset Class

Equity

ETF Category

Health

Assets

32.26M

PE Ratio

28.89

Breakdown by Country

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	5.73%	1,586
2	ALNY	Alnylam Pharmaceuticals, Inc.	5.26%	7,589
3	UNH	UnitedHealth Group Incorporated	5.24%	4,531
4	TMO	Thermo Fisher Scientific Inc.	3.64%	1,801
5	PODD	Insulet Corporation	3.62%	8,466
6	COR	Cencora, Inc.	3.55%	3,573
7	GILD	Gilead Sciences, Inc.	3.21%	6,979
8	A	Agilent Technologies, Inc.	3.02%	5,770
9	ISRG	Intuitive Surgical, Inc.	2.97%	2,270
10	ELAN	Elanco Animal Health Incorporated	2.76%	40,061
11	WST	West Pharmaceutical Services, Inc.	2.49%	2,217
12	DHR	Danaher Corporation	2.38%	3,518
13	CYTK	Cytokinetics, Incorporated	2.31%	12,036
14	WAT	Waters Corporation	2.15%	1,628
15	PCVX	Vaxcyte, Inc.	2.10%	9,720
16	DXCM	DexCom, Inc.	2.08%	7,927
17	ASND	Ascendis Pharma A/S	2.00%	2,885
18	MCK	McKesson Corporation	1.94%	664
19	DNLI	Denali Therapeutics Inc.	1.79%	30,833
20	BSX	Boston Scientific Corporation	1.75%	13,065
21	RVTY	Revvity, Inc.	1.75%	3,677
22	IDXX	IDEXX Laboratories, Inc.	1.75%	1,092
23	DYN	Dyne Therapeutics, Inc.	1.67%	34,335
24	BIIB	Biogen Inc.	1.63%	2,330
25	STTK	Shattuck Labs, Inc.	1.63%	87,726

Showing 25 of 117 holdings

Subscribe to see the full list

Activate Now

As of Oct 10, 2026